  |
The MedWatch April 2015 Safety Labeling Changes posting includes 55 products with safety labeling changes to the following sections:BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE.
The "Summary Page" table provides a listing of product names and safety labeling sections revised:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm446032.htm
The following drugs had modifications to the BOXED WARNING, CONTRAINDICATIONS, or WARNINGS AND PRECAUTIONS sections:
Actonel (risedronate sodium) Tablets
Actonel with Calcium (risedronate sodium tablets with calcium carbonate tablets, USP)
Adcirca (tadalafil) Tablets
Arthrotec (diclofenac sodium/misoprostol) Oral Tablets
Atelvia (risedronate sodium) Delayed-release Tablets
Bidil (isosorbide dinitrate/hydralazine hydrochloride) Tablets
Binosto (alendronate sodium) Effervescent Tablets for Oral Solution
Boniva (ibandronate sodium) Injection
Boniva (ibandronate sodium) Tablets
Didronel (etidronate disodium) Tablets
Edarbyclor (azilsartan medoxomil/chlorthalidone)
Erbitux (cetuximab)
Flucelvax (Influenza Vaccine)
Fosamax (alendronate sodium) Tablets and Oral Solution
Fosamax Plus D (alendronate sodium/cholecalciferol) Tablets
Herceptin (trastuzumab)
Lotrel (amlodipine besylate and benazepril hydrochloride) Capsules
Olysio (simeprevir) Capsules
Pomalyst (pomalidomide) Capsules
Prolia (denosumab)
Revatio (sildenafil) Tablets, Single Use Vials for Injection, and Oral Suspension
Selzentry (maraviroc)
Sporanox (itraconazole) Capsules and Oral Solution
Sutent (sunitinib malate)
Tudorza Pressair (aclidinium bromide inhalation powder)
Votrient (pazopanib) Tablets
You are encouraged to report all serious adverse events and product quality problems to FDA MedWatch at www.fda.gov/medwatch/report.htm
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
| This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
